Literature DB >> 2443380

Inhibition of in vitro hematopoiesis by hepatitis A virus.

F W Busch1, S de Vos, B Flehmig, F Herrmann, C Sandler, A Vallbracht.   

Abstract

Inoculation of human bone marrow with hepatitis A virus (HAV) resulted in a dose- and duration-of-incubation-dependent suppression of hematopoietic progenitor (CFU-GM, BFU-E, CFU-Mix) growth in vitro. Monocytic progenitors appeared to be least affected. While HAV inactivation by heat or beta-propiolactone and neutralization by specific antibodies completely abrogated hematopoietic inhibition, depletion of adherent bone marrow cells, and enrichment of progenitors did not alter the pattern of suppression, which also seemed to be independent of HuIFN-alpha, -beta, -gamma, and TNF. These findings support the concept that direct infection of progenitor cells by HAV may be responsible for hematologic changes commonly seen during early phases of infectious hepatitis and possibly for some cases of bone marrow failure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2443380

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Myelopoiesis in vitro is suppressed by hepatitis A virus.

Authors:  F W Busch; A Kunst; B Flehmig; H G Mergenthaler; G Pawelec; A Vallbracht
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 2.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

3.  Hepatitis A virus suppresses monocyte-to-macrophage maturation in vitro.

Authors:  Sabina Wünschmann; Britta Becker; Angelika Vallbracht
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Hepatitis B virus differentially suppresses myelopoiesis and displays tropism for immature hematopoietic cells.

Authors:  G K Sing; S Prior; A Fernan; G Cooksley
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil.

Authors:  F W Busch; U Schmittele; G Ehninger
Journal:  Blut       Date:  1990-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.